Amniotic Fluid Karyotyping

6,000.00

Amniotic Fluid Karyotyping is a prenatal diagnostic test that examines the chromosomes of fetal cells obtained from the amniotic fluid. The test analyzes the number and structure of chromosomes to detect genetic abnormalities such as:
• Down syndrome (Trisomy 21)
• Edwards syndrome (Trisomy 18)
• Patau syndrome (Trisomy 13)
• Other chromosomal abnormalities, deletions, duplications, or rearrangements
The test involves culturing fetal cells from the amniotic fluid and then examining their chromosomes under a microscope.

Enquiry Here

    Description

    Why It’s Done

    This test is usually recommended when there is a higher risk of chromosomal abnormalities, such as:
    • Advanced maternal age (usually over 35 years)
    • Abnormal results from prenatal screening tests (e.g., ultrasound or blood tests)
    • Family history of genetic disorders or chromosomal abnormalities
    • Previous pregnancy with chromosomal abnormalities
    • Exposure to certain medications or infections during pregnancy
    It helps parents and healthcare providers make informed decisions about pregnancy management.

    Preparation for the Test

    • Procedure: The test requires amniocentesis, where a needle is inserted through the mother’s abdomen into the uterus to withdraw amniotic fluid.
    • Fasting: Not usually required.
    • Medical Evaluation: A thorough ultrasound is done before the procedure to determine fetal position and amniotic fluid amount.
    • Consent: Informed consent is necessary as the procedure carries some risks (e.g., miscarriage).
    • Medications: Inform your healthcare provider about any medications, allergies, or health conditions.
    • Rest: Avoid strenuous activity before and after the procedure as advised by your doctor.